Literature DB >> 2833350

Antigenic phenotype and biological characteristics of two distinct sublines derived from a small cell lung carcinoma cell line.

H Watanabe1, T Takahashi, R Ueda, K R Utsumi, T Sato, Y Ariyoshi, K Ota, Y Obata, T Takahashi.   

Abstract

Two sublines, SCLC-MOA1 (MOA1) and SCLC-MOA2 (MOA2), were established from the SCLC-MO cell line, which was originally derived from an oat cell type of small cell lung carcinoma (SCLC). SCLC-MO showed typical culture morphology of SCLC, growing as tightly packed floating aggregates, while both MOA1 and MOA2 grew as a monolayer. MOA2 showed markedly shorter culture doubling time and higher colony forming efficiency than SCLC-MO and MOA1. When transplanted into nude mice, both SCLC-MO and MOA1 showed intermediate cell type histology, while MOA2 showed a picture of large cell carcinoma as non-SCLC. As for biomarkers, SCLC-MO showed a transitional state between the classic and the variant types, while MOA1 was the variant type. In contrast, MOA2 lost the biomarker characteristic of SCLC, showing rather non-SCLC type. SCLC-MO expressed NE-150 neuroendocrine antigen, but lacked PE-35 panepithelial antigen which is generally present on SCLC. It lacked also OE-130 epithelial antigen which is generally absent from SCLC. Thus, the phenotype was NE-150+/PE-35-/OE-130-, which was different from the major phenotype of SCLC, NE-150+/PE-35+/OE-130-. MOA1 was weakly positive for PE-35, showing NE-150+/PE-35 +/- /OE-130-, while MOA2 was positive for OE-130, but lost NE-150, i.e., NE-150-/PE-35+/OE-130+, showing a non-SCLC phenotype. Thus, a good concordance was observed between the antigenic phenotype and the biological characteristics of these SCLC lines. The results altogether suggested that a part of large cell carcinoma in the tumor of the patient may be derived from SCLC. Karyotype analysis showed that there were several marker chromosomes including deletion of chromosome 3p shared by these three cell lines, supporting the belief that MOA1 and MOA2 originated from SCLC-MO. Southern blot analysis showed the amplification of the L-myc related gene, probably rearranged L-myc, in the primary SCLC tumor as well as in SCLC-MO and MOA1. Northern blot analysis showed the 2.2-kilobase transcripts hybridized with a L-myc probe were observed in SCLC-MO and MOA1, but not in MOA2. In contrast, the c-myc transcript was detected only in MOA2. The activity of the myc gene family may contribute to certain biological characteristics of SCLC.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2833350

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  4 in total

1.  Complex intrachromosomal rearrangement in the process of amplification of the L-myc gene in small-cell lung cancer.

Authors:  Y Sekido; T Takahashi; T P Mäkelä; Y Obata; R Ueda; T Hida; K Hibi; K Shimokata; K Alitalo; T Takahashi
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

2.  Immunohistochemical examination of 11 cell lines derived from human head and neck squamous cell carcinomas, their recurrences or metastases.

Authors:  P Koldovsky; I Haas; H Bier; U Ganzer
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

3.  Epitope analysis of cluster 1 and NK cell-related monoclonal antibodies.

Authors:  T Hida; K Koike; Y Sekido; K Nishida; T Sugiura; Y Ariyoshi; T Takahashi; R Ueda
Journal:  Br J Cancer Suppl       Date:  1991-06

4.  Quantitative distribution of cluster 1 small cell lung cancer antigen in cancerous and non-cancerous tissues, cultured cells and sera.

Authors:  T Hirano; S Hirohashi; T Kunii; M Noguchi; Y Shimosato; Y Hayata
Journal:  Jpn J Cancer Res       Date:  1989-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.